About this trial
This research is being done to test a communication coaching intervention pilot designed to improve communication quality between adolescent/young adult cancer survivors (AYACS) and their friends/peers. The results of the study will help to understand how to best support adolescent/young adult cancer survivors, and may inform the development or future implementation of similar programs for cancer survivor populations.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participant is currently ≥18-35 years old
Participant is receiving cancer-directed care at Penn State Cancer Institute or Penn State Children's Hospital
Participant has completed all cancer-directed therapy and is at least 1 year from end of cancer treatment (based on date of last cancer-directed treatment)
Participant has access to a computer with internet capability
Disqualifiers
Participant is not fluent in written and spoken English
Participant with cognitive inability to participant in the study as determined by the study team
Participants with history of relapsed cancer
Trial design
Single group
Treatments tested in this trial
Asynchronous coaching and artificial intelligence (AI) Yoodli coach sessions
BehavioralParticipants will complete asynchronous individual sessions for Visits 2-4. Each visit will include a 60-minute interactive didactic session using Rise 360 software, with a 20-minute Yoodli AI coaching session (both Rise 360 and Yoodli will be accessed via website). Rise 360 sessions will cover topics related to communication style, multiple goals theory and how to apply concepts learned in being good communicators. Yoodli AI coaching session will be completed for the corresponding Rise 360 session before moving to the next visit's session. The 20-minute Yoodli AI coaching sessions will include coaching from the Yoodli AI coach and practicing various peer conversation situations. These sessions will consolidate and reinforce concepts learned in the didactic sessions. The Yoodli AI coach is programmed with input on relationship style (a communication tool to assess communication style) to deliver personalized coaching.
Treatment groups
Trial outcomes
Primary outcomes
Intervention Feasibility (Quantitative)
Quantitative feasibility will be collected based on visit attendance.
Intervention Feasibility (Qualitative)
Qualitative feasibility data will be collected from post-module mixed methods assessments, and exit interviews and focus groups.
Intervention Acceptability (Quantitative)
Quantitative acceptability will be collected using an acceptability questionnaire. Quantitative acceptability will be integrated with qualitative data from post-module mixed methods assessments, and exit interviews and focus groups to understand intervention acceptability.
Intervention Acceptability (Qualitative)
Qualitative acceptability data will be collected from post-module mixed methods assessments, and exit interviews and focus groups.
Secondary outcomes
Anxiety
Anxiety will be measured using the Anxiety (Emotional Distress-Anxiety-Short Form 8a) measure from the Patient Reported Outcomes Measurement Information System (PROMIS). It is an 8-item self-report questionnaire assessing anxiety symptoms over the past 7 days, including fear, tension, and worry. It is scored on a 5-point Likert scale (1=Never, 2=Rarely, 3=Sometimes, 4=Often, 5=Always).
Anxiety
Anxiety will be measured using the Anxiety (Emotional Distress-Anxiety-Short Form 8a) measure from the Patient Reported Outcomes Measurement Information System (PROMIS). It is an 8-item self-report questionnaire assessing anxiety symptoms over the past 7 days, including fear, tension, and worry. It is scored on a 5-point Likert scale (1=Never, 2=Rarely, 3=Sometimes, 4=Often, 5=Always).
Depression
Depression will be measured using the Depression (Emotional Distress-Depression-Short Form 8b) measure from the Patient Reported Outcomes Measurement Information System (PROMIS). It is an 8-item, self-report questionnaire assessing negative mood, views of self, and social cognition over the past seven days. It uses a 5-point scale (1=Never, 5=Always) to measure severity.
Depression
Depression will be measured using the Depression (Emotional Distress-Depression-Short Form 8b) measure from the Patient Reported Outcomes Measurement Information System (PROMIS). It is an 8-item, self-report questionnaire assessing negative mood, views of self, and social cognition over the past seven days. It uses a 5-point scale (1=Never, 5=Always) to measure severity.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.